Adverse Drug Reaction Bulletin (ADRB)

Adverse Drug Reaction Bulletin is a specialized review journal that provides comprehensive coverage of adverse drug reactions and drug safety. Each issue contains an invited article written by experts in pharmacology, toxicology, and clinical medicine, focusing on a specific drug class, therapeutic area, or clinical condition. Topics range from drug‑induced organ disorders (such as hepatotoxicity or pulmonary toxicity) to adverse effects of commonly used medications, antidotes for poisoning, and emerging safety concerns with new therapies. Articles are succinct, fully referenced, and designed to keep clinicians, pharmacists, and researchers up to date with the latest knowledge in drug safety. Unlike primary research journals, ADR Bulletin emphasizes critical reviews and practical insights, making it a valuable resource for healthcare professionals who need to understand the risks associated with pharmacological treatments. Its mission is to improve patient safety by disseminating authoritative information on adverse drug reactions, thereby guiding prescribing practices, monitoring strategies, and regulatory decisions. With its long history and consistent focus, ADR Bulletin has established itself as a trusted source in the field of pharmacovigilance and clinical pharmacology.

Adverse Drug Reaction Bulletin (ADRB) is :-

• International, Peer-Reviewed, Open Access, Refereed, Pharmacology, Pharmacy, Clinical Medicine, Drug Safety, Pharmacovigilance, hepatotoxicity or pulmonary toxicity, antidotes for poisoning, emerging safety concerns with new therapies , Online or Print , Bi-Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 0044-6394, E-ISSN: 2159-7774, Established: 1973,
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE